Skin n Skin Statistics

Total Valuation

Skin n Skin has a market cap or net worth of KRW 34.50 billion. The enterprise value is 37.19 billion.

Market Cap	34.50B
Enterprise Value	37.19B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Skin n Skin has 39.66 million shares outstanding.

Current Share Class	39.66M
Shares Outstanding	39.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.78%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	n/a
Float	27.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.38
PB Ratio	2.67
P/TBV Ratio	2.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.09
EV / Sales	2.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.12

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.54.

Current Ratio	1.61
Quick Ratio	0.66
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-16.77

Financial Efficiency

Return on equity (ROE) is -36.14% and return on invested capital (ROIC) is -17.99%.

Return on Equity (ROE)	-36.14%
Return on Assets (ROA)	-14.96%
Return on Invested Capital (ROIC)	-17.99%
Return on Capital Employed (ROCE)	-41.11%
Revenue Per Employee	172.88M
Profits Per Employee	-72.73M
Employee Count	84
Asset Turnover	0.57
Inventory Turnover	4.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.64% in the last 52 weeks. The beta is -0.11, so Skin n Skin's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	+12.64%
50-Day Moving Average	934.78
200-Day Moving Average	809.25
Relative Strength Index (RSI)	33.40
Average Volume (20 Days)	93,109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Skin n Skin had revenue of KRW 14.52 billion and -6.11 billion in losses. Loss per share was -173.40.

Revenue	14.52B
Gross Profit	4.97B
Operating Income	-6.12B
Pretax Income	-5.59B
Net Income	-6.11B
EBITDA	-5.53B
EBIT	-6.12B
Loss Per Share	-173.40

Full Income Statement

Balance Sheet

The company has 4.31 billion in cash and 7.00 billion in debt, giving a net cash position of -2.68 billion or -67.71 per share.

Cash & Cash Equivalents	4.31B
Total Debt	7.00B
Net Cash	-2.68B
Net Cash Per Share	-67.71
Equity (Book Value)	12.91B
Book Value Per Share	356.91
Working Capital	5.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.86 billion and capital expenditures -396.12 million, giving a free cash flow of -7.26 billion.

Operating Cash Flow	-6.86B
Capital Expenditures	-396.12M
Free Cash Flow	-7.26B
FCF Per Share	-183.05

Full Cash Flow Statement

Margins

Gross margin is 34.22%, with operating and profit margins of -42.12% and -42.07%.

Gross Margin	34.22%
Operating Margin	-42.12%
Pretax Margin	-38.50%
Profit Margin	-42.07%
EBITDA Margin	-38.05%
EBIT Margin	-42.12%
FCF Margin	n/a

Dividends & Yields

Skin n Skin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.08%
Shareholder Yield	-1.08%
Earnings Yield	-17.71%
FCF Yield	-21.04%

Stock Splits

The last stock split was on December 6, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Dec 6, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

Skin n Skin has an Altman Z-Score of -3.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.2
Piotroski F-Score	n/a